Drug Rehab Needs, despite Big Pharma cuts Increase
Big Pharma has billions of dollars with the recent closures and layoffs totaling 40,000 jobs lost so far and climbing. But the cuts in most Big Pharma companies will probably continue to be more, not less prescription drug rehabilitation programs need to be.
While some business interests do not always get rid of pharmaceutical plants and the closing of others are reducing the workforce to reduce costs and increase profits sag. For Big Pharma, like allState enterprises, the A and O is the baseline. Being in the business of improving health is not a factor in the numbers game, but it is worrying that millions of people in drug rehabilitation programs are or should be, because their products.
One article in the Guardian Unlimited, says that the Swiss pharmaceutical giant Novartis AG announced the dismissal of 2,500 employees landscape – is one of a series of reductions spread over Big Pharma. Last weekSanofi-Aventis in France has announced spending cuts and Bristol-Myers Squibb said it would cut 10% of workers and closing several factories. Most other large pharmaceutical companies have already taken measures to deal Amgen business losses, including Eli Lilly, Johnson & Johnson, Astra Zeneca, Pfizer, Glaxo Smith Kline, Merck, Schering-Plough, and – many of them names, drug rehab counselors, not just the equity investors are aware of.
One of the problems Big PharmaThe research addresses divisions producing too few new brand name drugs with patents on many brands profitable end. cheaper generic drugs instead of brand, and these gains are not to go into the pockets of Big Pharma. This is not to sell fewer drugs, but are more accessible. As for drugs, we will see more and more requests for addiction services drug rehabilitation.
Big Pharma has lost billions of dollars for drugs that have been assigned"Black box" warnings by the FDA and more billions of dollars in drugs that were withdrawn from the market due to risk death. As a result, more than ever people to trust the products of Big Pharma started and should be avoided, that prescription drugs are even remotely similar to drugs known dangerous.
For example, Merck's withdrawn arthritis painkiller Vioxx from its market in 2004 because of serious cardiovascular side effects. The cost of withdrawal Merck $ 2500000000 a year. MoreThe former Vioxx users were expected to move from arthritis drug Celebrex Pfizer – as Vioxx, but also with a black box warning. Instead, half of them on Celebrex, along with all other similar recipes. Not only does not collect Vioxx Pfizer business, but 60% of their customers Celebrex was due to security problems. Pfizer's profit in the Celebrex expects 4000000000 dollars a year, dropped to $ 2 billionth
Meanwhile, a new generation of medicines, with unknown side effects or dependency issues that could lead to drug rehabilitation, are being developed by biotech companies that are not big pharma players. Typically, you expect to be bought or acquired, because these drugs market is a threat to Big Pharma, Big Pharma has already represented the marketing infrastructure. These acquisitions are usually delayed until tests show that some are a bit 'safer and additions no obvious drug and drugs known to> Rehabilitation Centres.
Hence the need for drug rehabilitation is back to raise the doubt, despite the cut in Big Pharma. With millions of people dependent on prescription drugs and need drug detox and drug rehab now, and have addictive drugs, cheaper can already predict that there will be a greater need for years, even for the rehabilitation program structures of drugs in the next.
Drug Rehab needs will increase in spite of Big Pharma Cut Backs
Big Pharma has lost billions of dollars recently, with plant closures and layoffs totaling 40,000 jobs so far and climbing. But the cuts in most Big Pharma companies are likely to be more, not less, as a prescription drug rehabilitation programs necessary to drive the future.
While some companies are not always going to lower the pharmaceutical interests, the closure of other facilities and the reduction of labor costs and increase profits sagging. Big Pharma, as allState-owned enterprises, is the nuts and bolts on the bottom line. Being in the business improvement of health is not a factor in the numbers game, nor is concern that millions of people in drug rehabilitation programs, or should be, because their products.
An article in the Guardian Unlimited, says that the Swiss drug manufacturer Novartis AG, the dismissal of 2,500 employees announced belongs – on a series of cuts in Big Pharma is spreading across the landscape. Last WeekSanofi-Aventis has announced in France, spending cuts, and Bristol-Myers Squibb said it will cut 10% of workers and closing several factories. Most other major pharmaceutical companies are already taking steps to avoid loss of business, including Eli Lilly, Johnson & Johnson, AstraZeneca, Pfizer, GlaxoSmithKline, Merck, Amgen and Schering-Plow – many of them names that the consultant drug rehabilitation, not only stock market investors are familiar.
Among the problems, big pharmaFaces of the research departments of production are too few new brand name drugs with patents on many brands of profitability which will soon expire. Cheaper generic drugs will replace the brand, and these gains will not go into the pockets of Big Pharma. It will sell no fewer drugs, but are more accessible. As for drugs, we will see even more dependencies and requirements for drug rehabilitation services.
Big Pharma has received have lost billions of dollars earmarked for drugs,"Black box" warnings on the labels of the FDA and more billions of dollars for drugs from the market because of the risks of life has been withdrawn. As a result, more than ever, people began to distrust of large pharmaceutical and prevention of prescription drugs that even remotely similar to drugs known dangerous.
For example, Merck withdrew its arthritis painkiller Vioxx from the market in 2004 because of serious cardiovascular side effects. The withdrawal of Merck's cost 2.5 billion dollars annually. MostThe former Vioxx users were expected to switch to Pfizer's Celebrex arthritis drug – similar to Vioxx, but also with a black-box warning. Instead, half of which Celebrex, along with all other similar provisions. Not only that Pfizer does not pick up business Vioxx, Celebrex, but 60% of his clients went away, because for safety. Pfizer's Celebrex on profits, probably 4 billion dollars a year, dropped to $ 2 billion.
Meanwhile, a new generation of drugs with cause unknown side effects or problems, drug addiction rehabilitation could be the development of biotech companies that are not big pharma players. Expect to be purchased or acquired, in principle, because these drugs was a threat to the markets of large pharmaceutical companies represented, and Big Pharma marketing infrastructure already exists. These acquisitions are usually delayed until some testing shows that it is one thing clear, secure and supplements, medicines in the areas of drugs known> Rehab centers.
Hence the need for drug rehabilitation is that, despite the increase of the cuts in Big Pharma. With millions of people already addicted to drugs and require drug detox and drug rehab now, and can go with the cheaper drugs, we expect an even greater need for facilities for drug rehabilitation program for the next few years to see .
Hip-cost drug rehabilitation to the billions of "Big Pharma", engaged in marketing spend
Big Pharma spent nearly twice as much money for promotion and research and development of new drugs – like what they say about it. And the impact of any type of advertising is all over the country that deals with tens of thousands of items in drug rehabilitation and recovery centers for drug addicts and see.
In 2004, according to researchers at York University in Canada, major pharmaceutical companies have spent almost 25% of 235.4 billion dollars in revenue, approximately $ 60Billion, the promotion of their drugs – and probably underestimated, "said the researchers. But despite the demands of industry, research and development far superior to all other costs, R & D is only 13, 4%. The incessant marketing of drugs for the public and doctors can not prevent that require a factor of price increase of dependence on prescription drugs and the number of people, drugs and addiction detoxification.
Duecountless television, print, radio and Internet advertising, a prescription has become a way of life for most Americans. But the cost of the promotion of large pharmaceutical companies are not just for advertising, but also many promotional activities. For example, Big Pharma to promote their brands directly to individual physicians in the hope that the drug will be prescribed medications to another company. The industry average is $ 61,000 by the physician to promote their brands of pharmaceutical products to doctors throughCountries in 2004, the study found. However, can doctors and health difficulties in complying with all the drugs are, for articles in medical journals, so that errors such as incorrect combinations of drugs, overdoses and even addictive, and patients who are still employees or employees detoxification and drug treatment or need for drugs.
The authors limit their study in the United States because it is the only country for which the information is insufficient.The United States is the largest pharmaceutical market in the world, 43% of global sales and marketing expenses. With over 22 million consumers of prescription drugs, according to the Centers for Disease Control, the United States has probably the most deadly prescription drugs, drug abuse treatment and rehabilitation of drug in the world. How, why our health costs are the highest in the world, look elsewhere, at least one of the following reasons:Big Pharma to pass on the cost of support for us, the prices of their drugs.
The study argues that Big Pharma is focused on the market, instead of pretending to search, rescue care industry, it should be. But of course we know that the rising numbers of injuries and deaths are caused by medication, and the sky dramatically the number of people needing a rehabilitation program for prescription drugs.
Drug Rehab Costs Are Chump Change Compared To the Billions "Big Pharma" Spends On Marketing
Big Pharma, the company is almost twice as much money for the promotion, as they say it for research and development of new drugs – as opposed to what they do. And the effects of this promotion can be viewed over the country, where tens of thousands of prescription drugs treat problems in the areas of drug trafficking, detoxification and drug rehab centers.
In 2004, according to researchers at York University in Canada, Big Pharma spent nearly 25% of its $ 235.4 billion in sales, or about $ 60Billion, the promotion of drugs – and this is probably an underestimate, "said the researchers. But despite the demands of industry, research and development far more than all the other costs that were R & D spending at 13.4%. The relentless commercialization of drugs to the public and doctors can not help but be a factor in rising prices for prescription drug addiction and the number of people who have a prescription drug detox and drug rehab.
Because of theendless television, print, radio and Internet advertising, prescription drugs have become a life for most Americans. But Big Pharma promo costs are not just for advertising, they also many other promotional activities. For example, Big Pharma promotes its brands directly with individual doctors in the hope that their drug use will be imposed on drugs by other companies. The industry average of $ 61,000 per physician promotion of drugs to doctors about the brandsCountry in 2004, the study found. But doctors and medical personnel can trouble to have with all the drugs that lead to articles in medical journals, so that errors such as incorrect combinations of drugs, overdoses and even dependencies that depend on patients, or to become dependent and need drug detox or drug – Rehab.
The authors limited their study in the United States because there is the only country for which sufficient information.The U.S. is the world's largest market for pharmaceutical products, the 43% of global sales and promotion expenses. With more than 22 million prescription drug abusers, according to the Centers for Disease Control, America probably also most prescription drug deaths, addiction and prescription drug rehab treatments in the world. As for why our healthcare costs are the highest in the world, we need not look further at least one of these reasons:Big Pharma goes along the advertising cost to us in the price of its drugs.
The study to be said that big pharmaceutical market is used to benefit much from research, life-saving health-care industry it purports to be. But of course we already know that the growing number of injuries and deaths are caused by medication, and the sky-fast number of people needing a prescription drug rehab program.
WordPress ·